GlassScriptPhysician profile
George Washington
NPI 1629496955
$7,838.04
in general payments reported to CMS, 2019-2025
13 companies · $360 in 2025
The $360 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $2,704 · 2021: $2,582 · 2022: $1,243 · 2023: $523 · 2024: $291 · 2025: $360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,173.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $4,461.25 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $1,383.49 | 2020-2023 | |
| Abbvie INC. | $555.12 | 2023-2024 | Natrelle Saline-Filled Breast Implants, Alloderm, Botox |
| Stryker Corporation | $267.74 | 2022-2024 | Spy-Phi System |
| Mentor Worldwide LLC | $255.60 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Depuy Synthes Sales INC. | $235.28 | 2020 | |
| Davol INC. | $124.70 | 2022 | |
| Acell, INC. | $114.95 | 2020 | |
| Revance Therapeutics, INC. | $112.69 | 2024-2025 | Daxxify |
| Medline Industries LP | $111.86 | 2021 | |
| Kci USA, INC. | $100.14 | 2021 | |
| Medinc of Texas | $94.92 | 2025 | |
| Sientra, INC. | $20.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Washington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.